Pfizer issues warning letter on Geodon antipsychotic drug

09/1/2004 | Forbes

The FDA and Pfizer have sent a warning letter to physicians advising them the antipsychotic drug Geodon is linked to high blood sugar and diabetes. The warning letter grew from an FDA investigation of six of the most widely used antipsychotic drugs and led to an instruction to the makers to revise their labels to reflect the dangers. The other drugs are AstraZeneca's Seroquel, Bristol-Myers Squibb's Abilify, Eli Lilly's Zyprexa, Janssen's Risperdal and Novartis' Clozaril.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ